Sumitomo Pharma Co (STU:DPM) Cyclically Adjusted Book per Share: €6.80 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:DPM Sumitomo Pharma Co Ltd STU:DPM
71 GF Score
Price €6.46
GF Value €4.66
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sumitomo Pharma Co Cyclically Adjusted Book per Share?

Sumitomo Pharma Co STU:DPM -5.07% 71 Cyclically Adjusted Book per Share is €6.80 as of Mar. 2026. GuruFocus rates STU:DPM with a GF Score™ of 71/100 and a GF Value™ of €4.66 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted book value per share for the three months ended in Mar. 2026 was €4.013. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.80 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sumitomo Pharma Co's average Cyclically Adjusted Book Growth Rate was -3.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -1.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sumitomo Pharma Co was 6.40% per year. The lowest was -1.90% per year. And the median was 4.50% per year.

As of today (2026-07-30), Sumitomo Pharma Co's current stock price is €6.459. Sumitomo Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €6.80. Sumitomo Pharma Co's Cyclically Adjusted PB Ratio of today is 0.95.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sumitomo Pharma Co was 3.70. The lowest was 0.23. And the median was 1.30.


Sumitomo Pharma Co  (STU:DPM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sumitomo Pharma Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.459/6.80
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sumitomo Pharma Co was 3.70. The lowest was 0.23. And the median was 1.30.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sumitomo Pharma Co Cyclically Adjusted Book per Share Related Terms


Sumitomo Pharma Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co Cyclically Adjusted Book per Share Chart

Sumitomo Pharma Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.82 8.83 7.71 7.86 6.80

Sumitomo Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.86 7.26 7.10 6.69 6.80

STU:DPM vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted PB Ratio falls into.


STU:DPM
71GF Score
Sumitomo Pharma Co Ltd STU:DPM
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sumitomo Pharma Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sumitomo Pharma Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.013/112.7000*112.7000
=4.013

Current CPI (Mar. 2026) = 112.7000.

Sumitomo Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 9.055 98.100 10.403
201609 9.228 98.000 10.612
201612 9.744 98.400 11.160
201703 8.592 98.100 9.871
201706 9.537 98.500 10.912
201709 9.456 98.800 10.786
201712 9.729 99.400 11.031
201803 8.714 99.200 9.900
201806 9.158 99.200 10.404
201809 9.450 99.900 10.661
201812 9.820 99.700 11.100
201903 9.984 99.700 11.286
201906 10.088 99.800 11.392
201909 10.874 100.100 12.243
201912 10.795 100.500 12.105
202003 11.270 100.300 12.663
202006 11.241 99.900 12.681
202009 10.999 99.900 12.408
202012 10.907 99.300 12.379
202103 11.293 99.900 12.740
202106 10.892 99.500 12.337
202109 11.309 100.100 12.733
202112 11.757 100.100 13.237
202203 11.716 101.100 13.060
202206 11.962 101.800 13.243
202209 11.464 103.100 12.531
202212 11.186 104.100 12.110
202303 7.154 104.400 7.723
202306 6.853 105.200 7.342
202309 6.572 106.200 6.974
202312 5.507 106.800 5.811
202403 2.412 107.200 2.536
202406 2.383 108.200 2.482
202409 1.811 108.900 1.874
202412 2.596 110.700 2.643
202503 2.647 111.100 2.685
202506 2.662 111.700 2.686
202509 3.852 112.000 3.876
202512 3.984 113.000 3.973
202603 4.013 112.700 4.013

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €6.80 mean?
Sumitomo Pharma Co (STU:DPM) has a Cyclically Adjusted Book per Share of €6.80 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sumitomo Pharma Co and its competitors.
Is Sumitomo Pharma Co's Cyclically Adjusted Book per Share too high?
Sumitomo Pharma Co's current Cyclically Adjusted Book per Share is €6.80. Overall, Sumitomo Pharma Co has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sumitomo Pharma Co's Cyclically Adjusted Book per Share compare to ZTS?
Sumitomo Pharma Co's Cyclically Adjusted Book per Share of €6.80 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sumitomo Pharma Co and its competitors. Sumitomo Pharma Co's current Cyclically Adjusted Book per Share is €6.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumitomo Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Sumitomo Pharma Co (STU:DPM) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.66, compared to a current price of €6.46 — trading 38.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is €6.80. Sumitomo Pharma Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sumitomo Pharma Co (STU:DPM), the current Cyclically Adjusted Book per Share is €6.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sumitomo Pharma Co (STU:DPM) Overvalued in 2026?

Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued. The current stock price of €6.46 is trading 38.6% above its estimated GF Value™ of €4.66. GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.

Key valuation signals for STU:DPM:

  • Cyclically Adjusted Book per Share: €6.80
  • GF Value™: €4.66 vs. price of €6.46 (38.6% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the STU:DPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sumitomo Pharma Co Business Description

Address 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
71GF Score

Get the complete analysis for STU:DPM

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.46
Price
€4.66
GF Value